Lifebit logo

Powering Health Non-Profits

Lifebit turns Costly Research Barriers into Accessible Scientific Discovery

Supporting the Lupus Research Alliance’s DREAM platform — uniting molecular and clinico-phenotypic data across 9+ CROs in the US and Canada, so every researcher can analyse the full cohort without the data ever leaving its governed environment.

Meet the team

Maria Chatzou Dunford

CEO & Co-founder, Lifebit

Thorben Seeger

Chief Business Development Officer, Lifebit

Nate Raine

Chief Growth Officer, Lifebit

“If any research organisation is looking to make the most of their data management and have the impact within their community, connecting with the Lifebit team is a must.”

Grant Roesler

DREAM Platform Administrator, Lupus Research Alliance

Lifebit research environment case study results

Challenges

Outcomes

impact

100%

OMOP mapping

coverage of molecular and clinico-phenotypic data

3

Clinical sites

onboarded to the DREAM platform

100%

Adherence

to US and Canadian data governance requirements

30–90%

Lower cloud costs

through large-scale analysis optimisation

FAQs

A research platform built for non-profit lupus discovery

Lifebit’s federated platform underpins the Lupus Research Alliance’s DREAM environment. Researchers across 9+ CROs analyse harmonised molecular and clinico-phenotypic data inside one shared, governed workspace — without the cost or risk of moving sensitive datasets between sites.

What the DREAM platform delivers:

Distributed molecular and clinico-phenotypic data from 9+ CROs are mapped to OMOP and made queryable through one consistent layer — researchers can ask the same question across cohorts without rebuilding the data each time.

DREAM spans spreadsheet-style exploration, point-and-click analysis, and full Jupyter and RStudio environments. Clinicians, statisticians, and computational researchers each work in the interface that fits their workflow, against the same governed dataset.

US and Canadian data access agreements, Five Safes principles, and project-level approvals are enforced consistently across every researcher session — removing the manual burden of tracking compliance per dataset.

Large-scale analysis optimisation cuts cloud spend by 30–90%, freeing budget that the Lupus Research Alliance reinvests into research capacity rather than infrastructure.

Next step

Ready to see this in your environment?

Lifebit’s federated platform powers research at Genomics England, the NIH, Boehringer Ingelheim, the Lupus Research Alliance, and beyond. Yours could be next.

Federate everything. Move nothing. Discover more.


United Kingdom

3rd Floor Suite, 207 Regent Street, London, England, W1B 3HH United Kingdom

USA
228 East 45th Street Suite 9E, New York, NY United States

© 2026 Lifebit Biotech Inc. DBA Lifebit. All rights reserved.

By using this website, you understand the information being presented is provided for informational purposes only and agree to our Cookie Policy and Privacy Policy.